Newsletter
Meet Us at the 2022 ISSCR Annual Meeting In San Francisco, California; June 15-18 | ASC
Applied StemCell, Inc. is proud to announce that our poster abstract on our cGMP compliant iPSC cell genome editing platform for therapeutic applications was accepted, and we will be attending the ISSCR Annual Meeting in person this summer! Join us and learn about ASC’s new cGMP-iPSC manufacturing process and how our TARGATTTM-iPSC platform can facilitate the development of immune-oncology cell products, such as CAR-iNK cells.
Make an appointment to meet with our team!
Email: info@appliedstemcell.com
Event Details:
When: June 15-18, 2022
Where: Moscone West Convention Center, San Francisco, CA
Event URL: https://www.isscr.org/meetings-events/annual-meetings/isscr-annual-meeting-2022
Where: Moscone West Convention Center, San Francisco, CA
Event URL: https://www.isscr.org/meetings-events/annual-meetings/isscr-annual-meeting-2022
About Applied StemCell, Inc.
Applied StemCell, Inc. (ASC) is a fast-growing Gene & Cell Therapy CRO headquartered in California, USA. ASC was founded in 2008 with a goal to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. With more than 12 years of experience in genome editing and stem cell technologies, ASC is proud to develop innovative technology platforms offering services and products in the field of Stem Cells (iPSCs/ESCs, differentiated cells) and animal/cell models for disease modeling, antibody discovery & screening, bioproduction, AAV potency assays, cell therapy, and regenerative medicine. Our Cell and Gene Therapy Bioservice platform also includes consultation for Pre-IND filing and CMC processes.
More information can be found at www.appliedstemcell.com.
Media Contact:
Maki Ogawa
Marketing Director, Applied StemCell, Inc.
408-773-8007
maki.ogawa@appliedstemcell.com